Abstract
Vaccination after VITT Forty persons in whom thrombosis and thrombocytopenia had developed after an initial ChAdOx1 nCoV-19 vaccination were given a second dose of a Covid-19 vaccine, most commonly BNT162b2. None of the patients had a recurrence of thrombosis and thrombocytopenia.
Original language | English |
---|---|
Pages (from-to) | 95 |
Number of pages | 1 |
Journal | New England Journal of Medicine |
Volume | 386 |
Issue number | 1 |
DOIs | |
Publication status | Published - 22 Dec 2021 |
Bibliographical note
Funding Information: No funding information.Open Access: Free to read, but no Open Access licence. For personal use only. No other uses without permission.
Publisher Copyright: Copyright © 2022 Massachusetts Medical Society. All rights reserved.
Citation: Lacy, Joanne, Sue Pavord, and Kevin E. Brown. "VITT and Second Doses of Covid-19 Vaccine." New England Journal of Medicine 386.1 (2022): 95-95.
DOI: 10.1056/NEJMc2118507